Cargando…

Review of Treatment for Adenosine Deaminase Deficiency (ADA) Severe Combined Immunodeficiency (SCID)

Adenosine deaminase deficiency (ADA) is a purine salvage pathway deficiency that results in buildup of toxic metabolites causing death in rapidly dividing cells, especially lymphocytes. The most complete form of ADA leads to severe combined immune deficiency (SCID). Treatment with enzyme replacement...

Descripción completa

Detalles Bibliográficos
Autores principales:	Secord, Elizabeth, Hartog, Nicholas L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512634/ https://www.ncbi.nlm.nih.gov/pubmed/36172599 http://dx.doi.org/10.2147/TCRM.S350762

Ejemplares similares

Atypical Hemolytic Uremic Syndrome (aHUS) and Adenosine Deaminase (ADA)-Deficient Severe Combined Immunodeficiency (SCID)—Two Diseases That Exacerbate Each Other: Case Report
por: Bogdał, Anna, et al.
Publicado: (2021)

PEGylated Recombinant Adenosine Deaminase Maintains Detoxification and Lymphocyte Counts in Patients with ADA-SCID
por: Dorsey, Morna J., et al.
Publicado: (2023)

Correction to: PEGylated Recombinant Adenosine Deaminase Maintains Detoxification and Lymphocyte Counts in Patients with ADA-SCID
por: Dorsey, Morna J., et al.
Publicado: (2023)

Pegademase bovine (PEG-ADA) for the treatment of infants and children with severe combined immunodeficiency (SCID)
por: Booth, Claire, et al.
Publicado: (2009)

National experience with adenosine deaminase deficiency related SCID in Polish children
por: Dąbrowska-Leonik, Nel, et al.
Publicado: (2023)

Adenosine Deaminase (ADA) Level in Tubercular Pleural Effusion
por: Verma, S.K., et al.
Publicado: (2008)

Development of gene therapy: potential in severe combined immunodeficiency due to adenosine deaminase deficiency
por: Montiel-Equihua, Claudia A, et al.
Publicado: (2009)

Atypical presentation of adenosine deaminase 2 deficiency with bi‐allelic ADA2 mutation
por: Al‐shaikh, Reem, et al.
Publicado: (2022)

Combined Immunodeficiency Disease and Adenosine Deaminase Deficiency. A Molecular Defect
por: Baumgarten, Alexander
Publicado: (1976)

Adenosine Deaminase Deficiency – More Than Just an Immunodeficiency
por: Whitmore, Kathryn V., et al.
Publicado: (2016)

Distinct Roles of Adenosine Deaminase Isoenzymes ADA1 and ADA2: A Pan-Cancer Analysis
por: Gao, Zhao-wei, et al.
Publicado: (2022)

First Occurrence of Plasmablastic Lymphoma in Adenosine Deaminase-Deficient Severe Combined Immunodeficiency Disease Patient and Review of the Literature
por: Migliavacca, Maddalena, et al.
Publicado: (2018)

Inhibition of adenosine deaminase (ADA)-mediated metabolism of cordycepin by natural substances
por: Li, Gen, et al.
Publicado: (2015)

Diagnostic Value of Serum Adenosine Deaminase (ADA) Level for Pulmonary Tuberculosis
por: Salmanzadeh, Shokrollah, et al.
Publicado: (2015)

Polymorphisme de l'adénosine déaminase (ada) dans l'espèce bovine
por: Ansay, M, et al.
Publicado: (1972)

Novel Adenosine Deaminase 2 (ADA2) Mutations Associated With Hematological Manifestations
por: Albalawi, Reem, et al.
Publicado: (2021)

Novel ADA2 Compound Heterozygous Mutations Resulting in Deficiency of Adenosine Deaminase 2 in a Pair of Siblings
por: Guo, Li, et al.
Publicado: (2021)

Lentiviral Mediated ADA2 Gene Transfer Corrects the Defects Associated With Deficiency of Adenosine Deaminase Type 2
por: Hong, Ying, et al.
Publicado: (2022)

ELISA based assays to measure adenosine deaminases concentration in serum and saliva for the diagnosis of ADA2 deficiency and cancer
por: Luo, Wenwen, et al.
Publicado: (2022)

Adenosine deaminase deficiency: a review
por: Flinn, Aisling M., et al.
Publicado: (2018)

Successful Treatment With Ledipasvir/Sofosbuvir in an Infant With Severe Combined Immunodeficiency Caused by Adenosine Deaminase Deficiency With HCV Allowed Gene Therapy with Strimvelis
por: Tucci, Francesca, et al.
Publicado: (2018)

Brainstem Infarction in Immunodeficiency Identified as Adenosine Deaminase 2 Deficiency: Case Report
por: Oster, Christoph, et al.
Publicado: (2023)

Hematopoietic Cell Transplantation for Adenosine Deaminase Severe Combined Immunodeficiency—Improved Outcomes in the Modern Era
por: Ghimenton, Elisabetta, et al.
Publicado: (2022)

Severe Combined Immunodeficiency (SCID) and Its New Treatment Modalities
por: Wadbudhe, Akshad M, et al.
Publicado: (2023)

Relation of serum adenosine deaminase (ADA) levels with sputum smear conversion in patients with pulmonary tuberculosis
por: Okutan, Oguzhan, et al.
Publicado: (2006)

Neutropenia in patients with adenosine deaminase deficiency
por: Kim, Vy HD, et al.
Publicado: (2014)

Urogenital Abnormalities in Adenosine Deaminase Deficiency
por: Pajno, Roberta, et al.
Publicado: (2020)

Universal Newborn Screening for Severe Combined Immunodeficiency (SCID)
por: van der Burg, Mirjam, et al.
Publicado: (2019)

Use of adenosine deaminase (ADA) to diagnose suspected peritoneal tuberculosis in Rwanda: a cross-sectional study
por: Ntwari, Jules, et al.
Publicado: (2020)

Strimvelis(®) for Treating Severe Combined Immunodeficiency Caused by Adenosine Deaminase Deficiency: An Evidence Review Group Perspective of a NICE Highly Specialised Technology Evaluation
por: South, Emily, et al.
Publicado: (2018)

Vasculopathy, Immunodeficiency, and Bone Marrow Failure: The Intriguing Syndrome Caused by Deficiency of Adenosine Deaminase 2
por: Lee, Pui Y.
Publicado: (2018)

Drosophila Larval Development and Human Immunodeficiency: The Adenosine Deaminase Connection
Publicado: (2005)

Thymic epithelial cells of severe combined immunodeficiency (SCID) mice.
por: Lee, I., et al.
Publicado: (1994)

Hematopoietic Stem Cell Transplantation for Severe Combined Immunodeficiency (SCID)
por: Haddad, Elie, et al.
Publicado: (2019)

Changes in Adenosine Deaminase Activity in Patients with Type 2 Diabetes Mellitus and Effect of DPP-4 Inhibitor Treatment on ADA Activity
por: Lee, Jae-Geun, et al.
Publicado: (2011)

Levels of adenosine deaminase in some experimental animal tumours and the possible therapeutic effect of the ADA inhibitor 2-deoxy-coformycin.
por: Hall, J. G., et al.
Publicado: (1979)

Plasma Adenosine Deaminase (ADA)-1 and -2 Demonstrate Robust Ontogeny Across the First Four Months of Human Life
por: Odumade, Oludare A., et al.
Publicado: (2021)

Hemophagocytic inflammatory syndrome in ADA-SCID: report of two cases and literature review
por: Fratini, Elena Sophia, et al.
Publicado: (2023)

Discrimination of Exudative Pleural Effusions Based on Pleural Adenosine Deaminase (ADA)-C-Reactive Protein (CRP) Levels, and Their Combination: An Observational Prospective Study
por: Perlepe, Garifallia, et al.
Publicado: (2021)

Evaluation of the adenosine deaminase (ADA) G22A gene polymorphism with recurrent spontaneous abortion among Egyptian patients
por: Farhan, Hanan Mohamed, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_v6kkf17r2aereccd4dgk30oi4u